Clinical Trials

Accrual Status
Limit to SWOG Trials

654 Results

Active Filters

Closed
Phase
Accrual
56%
Published
SWOG Clinical Trial Number
S0512

Phase II Trial of BAY 43-9006 (Sorafenib; NSC-724772) in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma

Research Committee(s)
Melanoma
Activated
03-15-2006
Closed
01-01-2009
ClinicalTrials.gov Registry Number
NCT00329641
Closed
Phase
Accrual
68%
Published
SWOG Clinical Trial Number
S0505
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
S0520

Phase II Study of PXD101 (NSC-726630) in Relapsed and Refractory Aggressive B-Cell Lymphomas

Research Committee(s)
Lymphoma
Activated
01-01-2006
Closed
05-01-2009
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0509

A Phase II Study of Novel Oral Anti-Angiogenic Agent AZD2171 (NSC-732208) in Malignant Pleural Mesothelioma

Research Committee(s)
Lung Cancer
Activated
11-01-2005
Closed
04-01-2008
Closed
Phase
Accrual
72%
Published
SWOG Clinical Trial Number
S0514
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0350
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
S0517
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0430
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0435
Closed
Phase
Accrual
100%
Published
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0508

Phase II Trial of Combination Thalidomide plus Temozolomide in Patients with Metastatic Melanoma

Research Committee(s)
Melanoma
Activated
06-01-2005
Closed
01-01-2007
Closed
Phase
Accrual
29%
Published
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
S0418

A Phase II Study of SB-715992 (NSC-727990, IND-70273) in Taxane-Resistant Androgen-Independent Metastatic Prostate Cancer

Research Committee(s)
Genitourinary Cancer
Activated
04-01-2005
Closed
05-01-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0329
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0413

Phase II Study of GW572016 (NSC #727989) as First Line Therapy in Patients with Advanced or Metastatic Gastric Cancer

Research Committee(s)
Gastrointestinal Cancer
Activated
12-15-2004
Closed
05-15-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0312

A Phase II Study of IV Gemcitabine and Oral Capecitabine in Patients with Advanced Renal Cell Cancer

Research Committee(s)
Genitourinary Cancer
Activated
12-01-2004
Closed
08-15-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0415
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0420